Novo Nordisk to buy hypertension pill, Ocedurenone, from KBP Biosciences for $1.3 bn
COPENHAGEN: Novo Nordisk A/S, a biotechnology company based in Denmark, announced on Monday that it will acquire ocedurenone, a pill for uncontrolled hypertension, from KBP...
Novo Nordisk to acquire BIOCORP for EUR 154.4 million
PARIS, FRANCE: Novo Nordisk, a leading global healthcare company, has announced that it has entered into a share purchase agreement with BIO JAG, the main...